Premium
Growth Hormone Treatment in Adults with Growth Hormone Deficiency: Effect on Muscle Fibre Size and Proportions
Author(s) -
WHITEHEAD H.M.,
GILLILAND J.S.,
ALLEN I.V.,
HADDEN D.R.
Publication year - 1989
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1989.tb11246.x
Subject(s) - medicine , human growth hormone , endocrinology , growth hormone , hormone , placebo , growth hormone deficiency , growth hormone treatment , alternative medicine , pathology
Whitehead, H.M., Gilliland, J.S., Allen, I.V. and Hadden D.R. (Sir George E. Clark Metabolic Unit and the Department of Neuropathology, Royal Victoria Hospital, Belfast, Northern Ireland, UK). Growth hormone treatment in adults with growth hormone deficiency: effect on muscle fibre size and proportions. Acta Paediatr Scand [Suppl] 356: 65, 1989. The effect of a 6‐month period of substitution therapy with recombinant human growth hormone (rhGH) on muscle fibre size and muscle fibre type proportions has been investigated in a group of 13 adults with growth hormone deficiency. All had a peak growth hormone (GH) response to insulin‐induced hypoglycaemia of less than 7 mU/I. There was no statistically significant change in the lesser fibre diameter or fibre proportions of either type 1 or type 2 muscle fibres in the rhGH group, as compared with placebo.